XML 273 R86.htm IDEA: XBRL DOCUMENT v3.25.0.1
Operating Segments - Schedule of Operating Segments (Details) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues          
External $ 840 $ 1,972 $ 2,879 $ 1,347
Total 840 1,972 2,879 1,347
Segment loss (gain) 3,527 2,967 5,773 8,287 5,768
Company’s share of losses of company accounted for at equity, net 208 99 210 109
Loss on impairment of intangible asset 1,042
Finance expense (income), net (51) (147) (1,164) (5,818) 21
Tax expense (5) 13 22 14  
Loss 3,679 2,932 5,883 2,592 5,789
Segment Assets 10,482 9,892 11,182 10,605  
Segment Liabilities 1,826 3,114 1,595 4,156  
Drug Development [Member]          
Revenues          
External
Total
Segment loss (gain) 3,040 2,772 5,359 8,405 5,768
Segment Assets 6,834 4,290 7,069 9,664  
Segment Liabilities 1,742 2,741 1,441 4,021  
Online Sales [Member]          
Revenues          
External 840 1,972 2,879 1,347
Total 840 1,972 2,879 1,347
Segment loss (gain) 487 195 414 (118)
Segment Assets 3,648 5,602 4,113 941  
Segment Liabilities $ 84 $ 373 $ 154 $ 135